{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:40:36Z","timestamp":1777419636491,"version":"3.51.4"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":1269,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T00:00:00Z","timestamp":1655251200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>The angiotensin receptor-neprilysin inhibitor (ARNI) sacubitril\/valsartan (Sac\/Val) demonstrated to be superior to enalapril in reducing hospitalizations, cardiovascular and all-cause mortality in patients with ambulatory heart failure and reduced ejection fraction (HFrEF), in particular when it is maximally up-titrated. Unfortunately, the target dose is achieved in less than 50% of HFrEF patients, thus undermining the beneficial effects on the outcomes. In this study, we aimed to evaluate the role of Sac\/Val and its titration dose on reverse cardiac remodelling and determine which echocardiographic index best predicts the up-titration success.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>From January 2020 to June 2021, we retrospectively identified 95 patients (65.6 [59.1\u201372.8] years; 15.8% females) with chronic HFrEF who were prescribed Sac\/Val from the HF Clinics of 5 Italian University Hospitals and evaluated the tolerability of Sac\/Val high dose (the ability of the patient to achieve and stably tolerate the maximum dose) as the primary endpoint in the cohort. We used a multivariable logistic regression analysis, with a stepwise backward selection method, to determine the independent predictors of Sac\/Val maximum dose tolerability, using, as candidate predictors, only variables with a P-value &amp;lt; 0.1 in the univariate analyses. Candidate predictors identified for the multivariable backward logistic regression analysis were age, sex, body mass index (BMI), chronic kidney disease (CKD), chronic obstructive pulmonary disease (COPD), dyslipidaemia, atrial fibrillation, systolic blood pressure (SBP), baseline tolerability of ACEi\/ARBs maximum dose, left ventricle global longitudinal strain (LVgLS), LV ejection fraction (EF), tricuspid annulus plane systolic excursion (TAPSE), right ventricle (RV) fractional area change (FAC), RV global and free wall longitudinal strain (RVgLS and RV-FW-LS). After the multivariable analysis, only one categorical (ACEi\/ARBs maximum dose at baseline) and three continuous (younger age, higher SBP, and higher TAPSE), resulted significantly associated with the study outcome variable with a strong discriminatory capacity (area under the curve 0.874, 95% confidence interval (CI) (0.794\u20130.954) to predict maximum Sac\/Val dose tolerability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our study is the first to analyse the potential role of echocardiography and, in particular, of RV dysfunction, measured by TAPSE, in predicting Sac\/Val maximum dose tolerability. Therefore, patients with RV dysfunction (baseline TAPSE &amp;lt;16 mm, in our cohort) might benefit from a different strategy to titrate Sac\/Val, such as starting from the lowest dose and\/or waiting for a more extended period of observation before attempting with the higher doses.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.13982","type":"journal-article","created":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T03:41:42Z","timestamp":1655264502000},"page":"2909-2917","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Predictors of Sacubitril\/Valsartan High Dose Tolerability in a Real World Population with HFrEF"],"prefix":"10.1093","volume":"9","author":[{"given":"Valeria","family":"Visco","sequence":"first","affiliation":[{"name":"Chair of Cardiology, Department of Medicine, Surgery and Dentistry, Schola Medica Salernitana, University of Salerno , Salerno ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Radano","sequence":"additional","affiliation":[{"name":"Chair of Cardiology, Department of Medicine, Surgery and Dentistry, Schola Medica Salernitana, University of Salerno , Salerno ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Campanile","sequence":"additional","affiliation":[{"name":"Department of Cardiology, \u201cSan Giovanni di Dio e Ruggi D'Aragona\u201d Hopital-University , Salerno ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amelia","family":"Ravera","sequence":"additional","affiliation":[{"name":"Department of Cardiology, \u201cSan Giovanni di Dio e Ruggi D'Aragona\u201d Hopital-University , Salerno ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Silverio","sequence":"additional","affiliation":[{"name":"Chair of Cardiology, Department of Medicine, Surgery and Dentistry, Schola Medica Salernitana, University of Salerno , Salerno ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Masarone","sequence":"additional","affiliation":[{"name":"Heart Failure Unit, AORN Colli , Naples ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Pacileo","sequence":"additional","affiliation":[{"name":"Heart Failure Unit, AORN Colli , Naples ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Correale","sequence":"additional","affiliation":[{"name":"Cardiology Department, Ospedali Riuniti University Hospital , Foggia ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Mazzeo","sequence":"additional","affiliation":[{"name":"Cardiology Department, Ospedali Riuniti University Hospital , Foggia ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Dattilo","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Operative Unit of Cardiology, University of Messina , Messina ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Giallauria","sequence":"additional","affiliation":[{"name":"Department of Translational Medical Sciences, Federico II University , Naples ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Cuomo","sequence":"additional","affiliation":[{"name":"Department of Translational Medical Sciences, Federico II University , Naples ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Mercurio","sequence":"additional","affiliation":[{"name":"Department of Translational Medical Sciences, Federico II University , Naples ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo Gabriele","family":"Tocchetti","sequence":"additional","affiliation":[{"name":"Department of Translational Medical Sciences, Federico II University , Naples ,","place":["Italy"]},{"name":"Center for Basic and Clinical Immunology Research (CISI), Federico II University , Naples ,","place":["Italy"]},{"name":"Interdepartmental Center for Clinical and Translational Research (CIRCET), Federico II University , Naples ,","place":["Italy"]},{"name":"Interdepartmental Hypertension Research Center (CIRIAPA), Federico II University , Naples ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Di Pietro","sequence":"additional","affiliation":[{"name":"Chair of Cardiology, Department of Medicine, Surgery and Dentistry, Schola Medica Salernitana, University of Salerno , Salerno ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albino","family":"Carrizzo","sequence":"additional","affiliation":[{"name":"Chair of Cardiology, Department of Medicine, Surgery and Dentistry, Schola Medica Salernitana, University of Salerno , Salerno ,","place":["Italy"]},{"name":"Vascular Pathophysiology Unit, IRCCS Neuromed , Pozzilli ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodolfo","family":"Citro","sequence":"additional","affiliation":[{"name":"Department of Cardiology, \u201cSan Giovanni di Dio e Ruggi D'Aragona\u201d Hopital-University , Salerno ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gennaro","family":"Galasso","sequence":"additional","affiliation":[{"name":"Chair of Cardiology, Department of Medicine, Surgery and Dentistry, Schola Medica Salernitana, University of Salerno , Salerno ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmine","family":"Vecchione","sequence":"additional","affiliation":[{"name":"Chair of Cardiology, Department of Medicine, Surgery and Dentistry, Schola Medica Salernitana, University of Salerno , Salerno ,","place":["Italy"]},{"name":"Vascular Pathophysiology Unit, IRCCS Neuromed , Pozzilli ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Ciccarelli","sequence":"additional","affiliation":[{"name":"Chair of Cardiology, Department of Medicine, Surgery and Dentistry, Schola Medica Salernitana, University of Salerno , Salerno ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,6,15]]},"reference":[{"key":"2026012114153159100_ehf213982-bib-0001","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"2026012114153159100_ehf213982-bib-0002","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1177\/1060028020983522","article-title":"Evaluating Sacubitril\/Valsartan Dose Dependence on Clinical Outcomes in Patients With Heart Failure With Reduced Ejection Fraction","volume":"55","author":"Kido","year":"2021","journal-title":"Ann Pharmacother"},{"key":"2026012114153159100_ehf213982-bib-0003","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/ejhf.580","article-title":"Prospective Comparison of AwAtDIoGM, Morbidity in Heart Failure I. Efficacy of sacubitril\/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction, the PARADIGM-HF trial","volume":"18","author":"Vardeny","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026012114153159100_ehf213982-bib-0004","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/ejhf.1465","article-title":"Real-world treatment patterns of sacubitril\/valsartan: a longitudinal cohort study in Germany","volume":"21","author":"Wachter","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2026012114153159100_ehf213982-bib-0005","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s12325-018-0710-4","article-title":"An Early View of Real-World Patient Response to Sacubitril\/Valsartan: A Retrospective Study of Patients with Heart Failure with Reduced Ejection Fraction","volume":"35","author":"Antol","year":"2018","journal-title":"Adv Ther"},{"key":"2026012114153159100_ehf213982-bib-0006","first-page":"158","article-title":"Sacubitril-Valsartan in a routine community population: attention to volume status critical to achieving target dose","volume":"7","author":"Pharithi","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2026012114153159100_ehf213982-bib-0007","doi-asserted-by":"crossref","first-page":"882","DOI":"10.2459\/JCM.0000000000001018","article-title":"Sacubitril\/valsartan use in a real-world population of patients with heart failure and reduced ejection fraction","volume":"21","author":"Mapelli","year":"2020","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"2026012114153159100_ehf213982-bib-0008","doi-asserted-by":"crossref","first-page":"E1897","DOI":"10.3390\/jcm9061897","article-title":"Sacubitril\/Valsartan Improves Autonomic Function and Cardiopulmonary Parameters in Patients with Heart Failure with Reduced Ejection Fraction","volume":"9","author":"Giallauria","year":"2020","journal-title":"J Clin Med"},{"key":"2026012114153159100_ehf213982-bib-0009","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3390\/jcm8020262","article-title":"Early Effects of Sacubitril\/Valsartan on Exercise Tolerance in Patients with Heart Failure with Reduced Ejection Fraction","volume":"8","author":"Vitale","year":"2019","journal-title":"J Clin Med"},{"key":"2026012114153159100_ehf213982-bib-0010","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1002\/ehf2.13285","article-title":"Reverse remodelling by sacubitril\/valsartan predicts the prognosis in heart failure with reduced ejection fraction","volume":"8","author":"Moon","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2026012114153159100_ehf213982-bib-0011","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2026012114153159100_ehf213982-bib-0012","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.cardfail.2015.08.342","article-title":"Relationship Between Reverse Remodeling and Cardiopulmonary Exercise Capacity in Heart Failure Patients Undergoing Cardiac Resynchronization Therapy","volume":"22","author":"Mastenbroek","year":"2016","journal-title":"J Card Fail"},{"key":"2026012114153159100_ehf213982-bib-0013","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1161\/CIRCULATIONAHA.107.743120","article-title":"St John Sutton M, De Sutter J, Murillo J. Results of the Predictors of Response to CRT (PROSPECT) trial","volume":"117","author":"Chung","year":"2008","journal-title":"Circulation"},{"key":"2026012114153159100_ehf213982-bib-0014","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/S0735-1097(01)01637-0","article-title":"Impact of cardiac resynchronization therapy using hemodynamically optimized pacing on left ventricular remodeling in patients with congestive heart failure and ventricular conduction disturbances","volume":"38","author":"Stellbrink","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"2026012114153159100_ehf213982-bib-0015","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"16","author":"Lang","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026012114153159100_ehf213982-bib-0016","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jcmg.2011.08.026","article-title":"Echocardiographic assessment of right ventricular function: how to account for tricuspid regurgitation and pulmonary hypertension","volume":"5","author":"Ling","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026012114153159100_ehf213982-bib-0017","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.115.003866","article-title":"Sex- and Method-Specific Reference Values for Right Ventricular Strain by 2-Dimensional Speckle-Tracking Echocardiography","volume":"9","author":"Muraru","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026012114153159100_ehf213982-bib-0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ehjci\/jeu184","article-title":"Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI\/ASE\/Industry Task Force to standardize deformation imaging","volume":"16","author":"Voigt","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026012114153159100_ehf213982-bib-0019","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ssresearch.2015.04.008","article-title":"Multicollinearity in hierarchical linear models","volume":"53","author":"Yu","year":"2015","journal-title":"Soc Sci Res"},{"key":"2026012114153159100_ehf213982-bib-0020","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0895-4356(01)00341-9","article-title":"Internal validation of predictive models: efficiency of some procedures for logistic regression analysis","volume":"54","author":"Steyerberg","year":"2001","journal-title":"J Clin Epidemiol"},{"key":"2026012114153159100_ehf213982-bib-0021","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","article-title":"Index for rating diagnostic tests","volume":"3","author":"Youden","year":"1950","journal-title":"Cancer"},{"key":"2026012114153159100_ehf213982-bib-0022","doi-asserted-by":"crossref","DOI":"10.1111\/1755-5922.12435","article-title":"The reverse remodeling response to sacubitril\/valsartan therapy in heart failure with reduced ejection fraction","volume":"36","author":"Martens","year":"2018","journal-title":"Cardiovasc Ther"},{"key":"2026012114153159100_ehf213982-bib-0023","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/00015385.2019.1686226","article-title":"Determinants of maximal dose titration of sacubitril\/valsartan in clinical practice","volume":"76","author":"Martens","year":"2021","journal-title":"Acta Cardiol"},{"key":"2026012114153159100_ehf213982-bib-0024","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/imj.14749","article-title":"Tolerability and efficacy of sacubitril\/valsartan in clinical practice","volume":"51","author":"Nandal","year":"2021","journal-title":"Intern Med J"},{"key":"2026012114153159100_ehf213982-bib-0025","doi-asserted-by":"crossref","first-page":"6665","DOI":"10.1038\/s41598-020-63801-2","article-title":"Clinical and echocardiographic benefit of Sacubitril\/Valsartan in a real-world population with HF with reduced ejection fraction","volume":"10","author":"Polito","year":"2020","journal-title":"Sci Rep"},{"key":"2026012114153159100_ehf213982-bib-0026","article-title":"Effects of sacubitril valsartan on clinical and echocardiographic parameters of outpatients with heart failure and reduced ejection fraction","volume":"31","author":"Landolfo","year":"2020","journal-title":"Int J Cardiol Heart Vasc"},{"key":"2026012114153159100_ehf213982-bib-0027","article-title":"Sacubitril\/valsartan improves right ventricular function in a real-life population of patients with chronic heart failure: The Daunia Heart Failure Registry","volume":"27","author":"Correale","year":"2020","journal-title":"Int J Cardiol Heart Vasc"},{"key":"2026012114153159100_ehf213982-bib-0028","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jcmg.2010.10.008","article-title":"Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment","volume":"4","author":"Konstam","year":"2011","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026012114153159100_ehf213982-bib-0029","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/ehf2.12338","article-title":"Sacubitril-valsartan in heart failure and multimorbidity patients","volume":"5","author":"Rodil Fraile","year":"2018","journal-title":"ESC Heart Fail"},{"key":"2026012114153159100_ehf213982-bib-0030","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1002\/ejhf.639","article-title":"Network Labs Ultrasound in Heart Failure Study G. Right ventricular recovery during follow-up is associated with improved survival in patients with chronic heart failure with reduced ejection fraction","volume":"18","author":"Dini","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026012114153159100_ehf213982-bib-0031","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1161\/CIRCULATIONAHA.109.887570","article-title":"Effects of right ventricular ejection fraction on outcomes in chronic systolic heart failure","volume":"121","author":"Meyer","year":"2010","journal-title":"Circulation"},{"key":"2026012114153159100_ehf213982-bib-0032","article-title":"Sacubitril\/valsartan in the treatment of right ventricular dysfunction in patients with heart failure with reduced ejection fraction: a real-world study","author":"Yang","year":"2021","journal-title":"J Cardiovasc Pharmacol"},{"key":"2026012114153159100_ehf213982-bib-0033","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9103159","article-title":"Effects of Sacubitril\/Valsartan on the Right Ventricular Arterial Coupling in Patients with Heart Failure with Reduced Ejection Fraction","volume":"9","author":"Masarone","year":"2020","journal-title":"J Clin Med"},{"key":"2026012114153159100_ehf213982-bib-0034","doi-asserted-by":"crossref","first-page":"16335","DOI":"10.1038\/s41598-021-95787-w","article-title":"Clinical evidence of initiating a very low dose of sacubitril\/valsartan: a prospective observational analysis","volume":"11","author":"Kim","year":"2021","journal-title":"Sci Rep"},{"key":"2026012114153159100_ehf213982-bib-0035","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/cpf.12726","article-title":"Predictors of right ventricular function improvement with sacubitril\/valsartan in a real-life population of patients with chronic heart failure","volume":"41","author":"Correale","year":"2021","journal-title":"Clin Physiol Funct Imaging"},{"key":"2026012114153159100_ehf213982-bib-0036","article-title":"The Role of Oxidative Stress in Cardiovascular Aging and Cardiovascular Diseases","volume":"11","author":"Izzo","year":"2021","journal-title":"Life (Basel)"},{"key":"2026012114153159100_ehf213982-bib-0037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ehjcr\/ytaa205","article-title":"It is easy to see, but it is better to foresee: a case report on the favourable alliance between CardioMEMS and levosimendan","volume":"4","author":"Visco","year":"2020","journal-title":"Eur Heart J Case Rep"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ehf2.13982","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ehf2.13982","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/9\/5\/2909\/65352032\/eschf_9_5_2909.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/9\/5\/2909\/65352032\/eschf_9_5_2909.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:18:24Z","timestamp":1769023104000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/9\/5\/2909\/8323016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,15]]},"references-count":37,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,6,15]]},"published-print":{"date-parts":[[2022,10,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.13982","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,10]]},"published":{"date-parts":[[2022,6,15]]},"assertion":[{"value":"2021-12-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}